Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape

We read with interest the systematic review on inflammatory bowel disease (IBD) patients with coronavirus disease 2019 (COVID-19) published by D ’Amico et al.1 The authors provided a comprehensive and up-to-date picture on the epidemiologic and clinical characteristics of IBD patients affected by COVID-19. We would like to elaborate on some points covered in their review. In particular, D’Amico et al1 reported a cumulative prevalence o f COVID-19 among IBD patients of 0.4%. This prevalence rate appears to be comparable with that found in the general population.
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research